Browse

Molten metal anode solid oxide fuel cell for transportation-related auxiliary power units. (2017)
Patent
FAISAL, N.H., AHMED, R., GOOSEN, M.F., KATIKANENI, S.P. and SOUENTIE, S. 2020. Molten metal anode solid oxide fuel cell for transportation-related auxiliary power units. US patent 10,661,736, granted 26.05.2020. US publication number US20170334379, first published 23.11.2017. Available from: http://patft.uspto.gov/netacgi/nph-Parser?patentnumber=10661736

A vehicular power system, a vehicle and a method of providing auxiliary power to a vehicle using an auxiliary power unit that uses a molten metal anode solid oxide fuel cell rather than an internal combustion engine. The auxiliary power unit includes... Read More about Molten metal anode solid oxide fuel cell for transportation-related auxiliary power units..

Optical concentrator and associated photovoltaic devices. (2013)
Patent
MALLICK, T.K. and SELLAMI, N. 2013. Optical concentrator and associated photovoltaic devices. International patent application PCT/GB2012/053221. International publication number WO 2013/093487A2, published 27.06.2013. Available from: https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2013093487

Disclosed is a transmissive optical concentrator, comprising an elliptical collector aperture and a non-elliptical exit aperture, the concentrator being operable to concentrate radiation incident on said collector aperture. The body of said concentra... Read More about Optical concentrator and associated photovoltaic devices..

Use of CYP1B1 inhibitors for treating cancer. (2001)
Patent
MURRAY, G.I., MELVIN, W.T. and MCFADYEN, M. 2001. Use of CYP1B1 inhibitors for treating cancer. International patent application PCT/GB2001/000548. International publication number WO/2001/058444 (WO 01/58444 A1), published 16.08.2001. Available from: https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2001058444

CYP1B1 proteins and their role in metabolising or inactivating anti-cancer drugs are disclosed, together with compositions for treating cancer comprising a substance capable of inhibiting CYP1B1 protein and an anti-cancer drug (e.g. docetaxel, paclit... Read More about Use of CYP1B1 inhibitors for treating cancer..